Search results for "Drug Interaction"

showing 10 items of 246 documents

α-Adrenoceptor Interaction of Tetrandrine and Isotetrandrine in the Rat: Functional and Binding Assays

1998

Abstract The action of 1S,1′S-tetrandrine, a bisbenzyltetrahydroisoquinoline alkaloid, on α1-adrenoceptors has been compared with that of its isomer 1R,1′S-isotetrandrine. The work includes binding assays to analyse the affinity of these products for the [3H]prazosin binding site of rat cerebral cortical membranes and functional studies on rat isolated aorta to examine the effects of both alkaloids on intracellular calcium processes related or not to α-adrenoceptor activation. A radioligand receptor-binding study showed that both compounds interacted with the α1-adrenoceptors displacing [3H]prazosin from the specific binding site. The Ki values (inhibition constants) were 0.69±0.12 and 1.6±…

StereochemistryPharmaceutical Sciencechemistry.chemical_elementAorta ThoracicIn Vitro TechniquesBiologyPharmacologyCalciumTritiumBenzylisoquinolinesBinding CompetitiveMuscle Smooth VascularCalcium in biologyNorepinephrinechemistry.chemical_compoundAlkaloidsPrazosinmedicineExtracellularAnimalsDrug InteractionsRats WistarCerebral CortexPharmacologyBinding SitesMolecular StructureAlkaloidBiological activityPrazosinReceptors Adrenergic alphaCalcium Channel BlockersRatsTetrandrinechemistryCalciumFemaleIntracellularMuscle ContractionProtein Bindingmedicine.drugJournal of Pharmacy and Pharmacology
researchProduct

Specific interactions of monotetrahydrofuranic annonaceous acetogenins as inhibitors of mitochondrial complex I.

2000

Annonaceous acetogenins (ACG) are a wide group of cytotoxic compounds isolated from plants of the Annonaceae family. Some of them are promising candidates to be a future new generation of antitumor drugs due to the ability to inhibit the NADH:ubiquinone oxidoreductase of the respiratory chain (mitochondrial complex I), main gate of the energy production in the cell. ACG are currently being tested on standard antitumor trials although little is known about the structure activity relationship at the molecular level. On recent studies, the relevance of several parts of the molecule for the inhibitory potency has been evaluated. Due to the great diversity of skeletons included in this family of…

StereochemistryRespiratory chainHerb-Drug InteractionsToxicologyMitochondria HeartLactonesOxidoreductaseMultienzyme ComplexesMoleculeMoietyStructure–activity relationshipAnimalsDrug InteractionsNADH NADPH OxidoreductasesEnzyme InhibitorsFuransAlkylChromatography High Pressure Liquidchemistry.chemical_classificationElectron Transport Complex IbiologyPlant ExtractsGeneral Medicinebiology.organism_classificationAntineoplastic Agents PhytogenicchemistryElectron Transport Complex IBiochemistryAnnonaceaeSeedsCattlePhytotherapyChemico-biological interactions
researchProduct

The effect of chitosan on the bioaccessibility and intestinal permeability of acyclovir

2019

Chitosan is object of pharmaceutical research as a candidate permeability enhancer. However, chitosan was recently shown to reduce the oral bioavailability of acyclovir in humans. The effect of chitosan on two processes determining the oral bioavailability of acyclovir, bioaccessibility and intestinal absorption, was now investigated. Acyclovir's bioaccessibility was studied using the dynamic TNO gastro-Intestinal Model (TIM-1). Four epithelial models were used for permeability experiments: a Caco-2 cell model in absence and presence of mucus and both rat and porcine excised intestinal segments. Study concentrations of acyclovir (0.8 g/l) and chitosan (1.6 g/l and 4 g/l) were in line with t…

SwineAcyclovirPharmaceutical ScienceBiocompatible Materials02 engineering and technologyPharmacology030226 pharmacology & pharmacyIN-VITRO EVALUATIONIntestinal absorptionChitosanchemistry.chemical_compound0302 clinical medicineDrug InteractionsPharmacology & PharmacyGeneral MedicinePermeation021001 nanoscience & nanotechnologyMOLECULAR-WEIGHTJejunum0210 nano-technologyLife Sciences & BiomedicineBiotechnologyAbsorption (skin)Antiviral AgentsPermeability03 medical and health sciencesOrgan Culture TechniquesIn vivomedicineAnimalsHumansBiologyABSORPTION ENHANCERSChitosanScience & TechnologyIntestinal permeabilityCACO-2Caco-2medicine.diseaseTRANSPORTRatsBioavailabilityMODELIntestinal AbsorptionchemistryCOMMON EXCIPIENTSCaco-2Intestinal tissue segmentsCaco-2 CellsTNO gastro-Intestinal Model (TIM-1)SYSTEMPOORLY ABSORBABLE DRUGSTRACTEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy.

2010

Drugs derived from natural resources represent a significant segment of the pharmaceutical market as compared to randomly synthesized compounds. It is a goal of drug development programs to design selective ligands that act on single disease targets to obtain highly effective and safe drugs with low side effects. Although this strategy was successful for many new therapies, there is a marked decline in the number of new drugs introduced into clinical practice over the past decades. One reason for this failure may be due to the fact that the pathogenesis of many diseases is rather multi-factorial in nature and not due to a single cause. Phytotherapy, whose therapeutic efficacy is based on th…

Systems biologyClinical BiochemistryPharmaceutical marketHerb-Drug InteractionsPharmacologylaw.inventionMulti targetlawDrug DiscoveryOils VolatileAnimalsHumansDrug InteractionsPharmacologyChemistryPlant ExtractsDrug SynergismPlantsClinical PracticeDrug developmentMolecular MedicinePlant PreparationsPhytotherapySignalling cascadesFunction (biology)PhytotherapyCurrent drug targets
researchProduct

Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

1991

Synthetic human and ovine corticotropin-releasing hormone (hCRH, oCRH) are commonly used as a diagnostic tool of the hypothalamo-pituitary-adrenal axis. In this paper reports about side effects after various modes of CRH-application are analyzed and compared to our corresponding data of human studies with hCRH and oCRH. Generally, CRH is well tolerated after single administration and interval-application of standard doses, although minor side effects appear sometimes after higher doses (greater than 200 micrograms hCRH, oCRH) of CRH-bolus-injections. Predominantly the cardiovascular system (e.g. tachycardia, hypotension, flushing) is affected; neuropsychological symptoms are only seen spora…

TachycardiaSingle administrationmedicine.medical_specialtyContinuous infusionCorticotropin-Releasing HormoneDizzinessCorticotropin-releasing hormoneBiological ClocksRisk FactorsInternal medicineTachycardiaDrug DiscoverymedicineFlushingAnimalsHumansIn patientDrug InteractionsGenetics (clinical)SheepHuman studiesDose-Response Relationship Drugbusiness.industryRespirationHead injuryGeneral Medicinemedicine.diseaseHormonesEndocrinologyAnesthesiaMolecular Medicinemedicine.symptombusinessHormoneKlinische Wochenschrift
researchProduct

Effect of polybrominated biphenyls on bromobenzene lethality in mice.

1977

Polybrominated biphenyls (PBBs) are inducers of hepatic microsomal cytochrome P450 and P1 450 in rats and mice. The purpose of this study was to determine, in mice, the effect of PBBs on the lethality of the hepatotoxin bromobenzene. Female NMRI mice were administered a single ip injection of 150 mg/kg PBBs and other mice received phenobarbital (PB), 100 mg/kg daily for 3 days, or 3‐methylcholanthrene (MC), 20 mg/kg daily for 3 days. At 24 hr after PB or MC and 24, 48, and 96 hr after PBBs animals received 3,150 mg/kg bromobenzene ip (LD85) and the time to death was recorded. Both PB and MC enhanced bromobenzene lethality and decreased the median time to death (LT50) from 23 hr in controls …

Time FactorsStereochemistryPolybrominated BiphenylsPharmacologyToxicologyLethal Dose 50chemistry.chemical_compoundMicemedicineAnimalsDrug InteractionsbiologyBiphenyl CompoundsHepatotoxinCytochrome P450PollutionGlutathionechemistryLiverBromobenzeneNmri micePhenobarbitalMicrosomebiology.proteinLethalityPhenobarbitalPolybrominated BiphenylsFemalemedicine.drugBromobenzenesMethylcholanthreneJournal of toxicology and environmental health
researchProduct

Interaction of cimetidine with metoprolol, propranolol, or atenolol.

1981

business.industryAdrenergic beta-AntagonistsGeneral MedicinePropranololPharmacologyAtenololPropranololPropanolaminesAtenololmedicineHumansDrug InteractionsCimetidinebusinessmedicine.drugMetoprololMetoprololLancet (London, England)
researchProduct

Incidence of potential drug interactions in a transplant centre setting and relevance of electronic alerts for clinical practice support

2013

Background Adverse drug events may occur as a result of drug–drug interactions (DDIs). Information technology (IT) systems can be an important decision-making tool for healthcare workers to identify DDIs.Objective The aim of the study is to analyse drug prescriptions in our main hospital units, in order to measure the incidence and severity of potential DDIs. The utility of clinical decision-support systems (CDSSs) and computerised physician order entry (CPOE) in term of alerts adherence was also assessed. DDIs were assessed using a Micromedex healthcare series database.Methods The system, adopted by the hospital, generates alerts for prescriptions with negative interactions and thanks to a…

computerised physicians order entrySafety Managementmedicine.medical_specialtymedicine.medical_treatmentHealth Informaticslcsh:Computer applications to medicine. Medical informaticsHospitals SpecialClinical decision support systemMedical Order Entry Systemslaw.inventionPatient safetyHealth Information ManagementlawHumansMedicineDrug Interactionsclinical decision-support systemMedical prescriptionIntensive care medicineDialysisRetrospective Studiesbusiness.industryIncidenceIncidence (epidemiology)Retrospective cohort studyOrgan TransplantationDecision Support Systems ClinicalIntensive care unitComputer Science ApplicationsClinical Alarmslcsh:R858-859.7businessAbdominal surgeryJournal of Innovation in Health Informatics
researchProduct

Fine-tuning lexical bundles : a methodological reflection in the context of describing drug-drug interactions

2018

This chapter has two major aims. First, it attempts to extend earlier research on recurrent phraseologies used in the pharmaceutical field (Grabowski 2015) by exploring the use, distribution and functions of lexical bundles found in English texts describing drug-drug interactions. Conducted from an applied perspective, the study uses 300 text samples extracted from DrugDDI Corpus originally collected in the Drugbank database (Segura-Bedmar et al. 2010). Apart from presenting new descriptive data, the second aim of the chapter is to reflect on the ways lexical bundles have been typically explored across different text types and genres. The problems discussed in the chapter concern the method…

drug-drug interactionslexical bundlescorpus-driven approachpharmaceutical texts
researchProduct

A minireview on NHE1 inhibitors. A rediscovered hope in oncohematology.

2015

Background: Na+/H+ exchanger-1 (NHE-1) is involved in pH regulation and is up-regulated in different malignancies. Activation of NHE-1 is one way for allowing cells to avoid intracellular acidification and protect them against apoptosis. Inhibitors of NHE-1 are able to decrease intracellular pH and induce apoptosis. Some statins can also act by partial inhibition of NHE-1. This review presents progress in understanding the mechanisms of action of these inhibitors, connections with certain genetic mutations and acquired treatment resistance, as well as new patents on them. Methods: A MEDLINE search for original and review articles using key terms, Na+/H+ exchanger, leukemia, cariporide, and …

lovastatinlcsh:MedicineApoptosisPharmacologyGuanidinesAmiloridep-glycoproteinhemic and lymphatic diseasesDrug InteractionsSulfonesCation Transport ProteinsSodium-Hydrogen Exchanger 1leukemiaMyeloid leukemiaHydrogen-Ion ConcentrationSorafenibUp-RegulationLeukemiaLeukemia Myeloid AcuteImatinib MesylateSignal transductionTyrosine kinasemedicine.drugSignal TransductionSorafenibNiacinamideisoprenylationSodium-Hydrogen Exchangersbcr/ablAntineoplastic AgentsGenes ablGeneral Biochemistry Genetics and Molecular BiologystatinsPatents as TopicCell Line TumorLeukemia Myelogenous Chronic BCR-ABL PositivemedicineHumansProtein Kinase Inhibitorscariporidena+/h+ exchangerTumor hypoxiabusiness.industryPhenylurea Compoundslcsh:ROsmolar Concentrationintracellular phmedicine.diseaseImatinib mesylatefms-Like Tyrosine Kinase 3Fms-Like Tyrosine Kinase 3MutationCancer researchTumor Hypoxiaflt3/itdHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessHeme Oxygenase-1DNA DamageBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct